Press Release

Blue Charm Adherence Inc. Closes Investment Offering utilizing the NSIETC

March 22, 2021
Return to all articles

Blue Charm Adherence is pleased to announce the successful closure of its investment offering utilizing the Nova Scotia Innovation Equity Tax Credit. The organization exceeded its second-round financing objective.

Greg Patey, CEO of Blue Charm Adherence, highlighted, "We are very pleased with the level of support during this offering from both within Nova Scotia and also outside the province. This truly shows the level of interest and commitment Blue Charm is garnering as we quickly approach market entry. The funding will support our launch and hiring plans, and I couldn't have asked for a better result."

About Blue Charm AdherenceBlue Charm Adherence is a healthcare company providing patients with interactive self-help platforms and behavioral modification tools that assist in increasing overall understanding of disease-related health information and medication adherence. The Blue Charm Adherence mobile application was created in accordance with patient-centric design principles, while the software engine, AdherencyRx™, provides a level of unparalleled sophistication driven by brand strategy and the associated clinical data.

For questions, please contact:

Dr. Greg Patey
CEO
Blue Charm Adherence Inc.
Email: g.patey@bluecharm.io

Articles you might like

Insights

Empowering Patients: The Crucial Role of Education in Respiratory Disease Management

Respiratory Therapist with seven years of experience highlights the importance of patient education in managing respiratory diseases. This post reveals that a significant portion of COPD and Asthma patients receive an insufficient amount of education on medication use and disease management.
Insights

Five Insights from Blue Charm’s Respiratory Program in Partnership with the Canadian Lung Association

At Blue Charm, we hear directly from patients about the challenges they face, things they need, and impact of their medications. In today’s article we’re sharing a few insights from our asthma and COPD patients. 
Insights

The Next Frontier in Real-World Evidence: Unlocking the Patient Voice

The promise of Real-World Evidence/Data has always been to support clinical decision making with the highest possible quality of evidence. In practice, what does this actually mean and how does it enable us to provide better care for patients?